12
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Enhanced Oxidative Response of Polymorphonuclear Leukocytes from Synovial Fluids of Patients with Rheumatoid Arthritis

, &
Pages 159-169 | Received 24 Jul 1987, Published online: 07 Jul 2009

References

  • Zvaifler N J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv. Immunol. 1973; 16: 265–336
  • Winchester R J, Agnello V, Kunkel H G. Gamma globulin complexes in synovial fluid of patients with rheumatoid arthritis. Partial characterisation and relationship to lowered complement levels. Clin. Exp. Immunol. 1970; 6: 689–706
  • Male D, Roitt I M, Hay R C. Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis. Clin. Exp. Immun. 1980; 39: 297–306
  • Bedwell A E, Elson C J, Carter S D, Dieppe D A, Hutton C W, Czudek R. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies. Ann. Rheum. Dis 1987; 46: 55–64
  • Goldstein I M, Roes D, Kaplan H B, Weissman G. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocystosis. J. Clin. Invest. 1975; 56: 1155–63
  • Weiss S J, Ward P A. Immune complex induced generation of oxygen metabolites by human neutrophils. J. Immunol 1982; 129: 309–13
  • McCord J. Free radicals and inflammation: Protection of synovial fluids by superoxide dismutase. Science 1974; 185: 529–31
  • Kellogg E W, Fridovich I. Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J. Biol. Chem. 1975; 250: 8812–17
  • Lunec J, Halloran P, White A G, Dormandy T L. Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J. Rheumatol. 1981; 8: 233–45
  • Carrol R W. 1-Antitrypsin: Molecular pathology, leukocytes and tissue damage. J. Clin. Invest. 1986; 78: 1427–31
  • Weiss S J, Peppin G, Ortiz X, Ragsdale C, Test S T. Oxidative autoaction of latent collagenase by human neutrophils. Science 1985; 227: 747–9
  • Burkhardt H, Schwingel M, Menninger H, MaCartney HW, Tschesche H. Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocyte activation of latent collagenase inhibition by SDS and catalase. Arth. Rheum. 1986; 29: 379–87
  • Greenwald R A, May W W. Effect of oxygen-derived free radicals on hyaluronic acid. Arth. Rheum. 1980; 23: 455–63
  • Gay JC, Beckman J K, Brash A R, Oates J A, Lukens J N. Enhancement of chemotactic factor-stimulated neutorophil oxidative metabolism by Leukotriene B4. Blood. 1984; 64: 780–5
  • Shalaby M R, Aggrawal B B, Rindoknecht E, Svedersky L P, Finkle B S, Palladine M A. Activation of human polymorphonuclear neutrophil functions by Interferon - and tumor necrosis factors. J. Immunol. 1985; 135: 2069–73
  • Klebanoff S J, Vadas M A, Harlan J M, Sparks L H, Gamble J R, Agosti J M, Waltersdorph A M. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 1986; 136: 4220–5
  • Van Epps D E, Garcia M L. Enhancement of neutrophil function as a result of prior exposure to chemotactic factor. J. Clin. Invest. 1980; 66: 167–7
  • English D, Roloff J S, Lukens J N. Chemotactic factor enhancement of superoxide release from fluoride and phorbol myristate acetate stimulated neutrophils. Blood. 1981; 58: 129–34
  • Davidson E M, Rae S A, Smith M J. Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann. Rheu. Dis. 1983; 42: 677–9
  • Klickstein L B, Shapleigh C, Goetzl E J. Lipoxygenation of arachidonic acid as a source of Polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J. Clin. Invest. 1980; 66: 1166–70
  • Duff G, DiGiovinef Manson J, Dickens E, Poole S, Nuki G., Interleukin 1 (IL-1) and tumor necrosis factor (TNF) in human arthritis (Strangeways Research Laboratory 75th anniversary symposium, Cory, proceed. No. 2, The control of tissue damage)
  • Zvaifler N J. Breakdown products of C3 in human synovial fluids. J Clin. Invest. 1969; 48: 1532–42
  • Ruddy S, Austen K F. The complement system in rheumatoid synovis I. An analysis of complement component activities in rheumatoid synovial fluids. Arth. Rheum. 1970; 13: 713–23
  • Dooley D C, Simpson J F, Meryman H T. Isolation of large numbers of fully viable human neurophils: a preparative technique using percoll density gradient centrifugation. Exp. Hematol. 1982; 10: 591–9
  • Ennist D L, Jones K H. Rapid method for identification of macrophages in suspension by acid alpha-napthyl acetate esterase activity. J. Histochem. Cytochem. 1983; 31: 960–3
  • Babior B M, Kipnes S, Carnutte J T. Biological defence mechanisms the production by leukocytes of superoxide, a potential bactericidal agent. J. Clin Invest. 1973; 52: 741–4
  • Wright J F, Hunter W M. A convenient replacement for cyanogen bromide activated solid phases by immunoradiometric assays. J. Immun. Meth. 1982; 48: 311–256
  • Clement L T, Lehmeyer J E, Gartland G L. Identification of neutrophil subpopulations with monoclonal antibodies. Blood 1983; 61: 326–32
  • Borregaard N, Heiple J M, Simons E R, Clark R A. Subcellular localization of the b-cytochrome component of the human neutrophil microbial oxidase: translocation during activation. J. Cell. Biol. 1983; 97: 52–61
  • Bender J G, van Epps D E, Searles R, Willesus RC, Jr. Altered function of synovial fluid granulocytes in patients with acute inflammatory arthritis. Inflammation 1986; 10: 443–454
  • James D W, Betts W H, Cheland L G. Chemiluminescense of polymorphonuclear leukocytes from rheumatoid joints. J. Rheumatol. 1983; 10: 185–89
  • De Chatelet L R, Long G D, Shirley P S, Bass D A, Thomas M J, Henderson F W, Cohen M S. Mechanism of the luminol dependent chemiluminescence of human neutrophils. J. Immunol. 1982; 129: 1589–93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.